Radio-Oncology Solothurn AG

What Radio-Oncology Solothurn AG does

Radio-Onkologie Solothurn AG is a Swiss radiation oncology institute established on 25 November 2011 as a joint venture between regional hospital operator Solothurner Spitäler AG and the university hospital Inselspital Bern. Operating from a single facility within the new building (Haus 1, 1st basement level) of Bürgerspital Solothurn at Schöngrünstrasse 42, the company delivers external beam radiation therapy to cancer patients primarily from Canton of Solothurn. Approximately 24 staff across secretariat, radiology specialists, medical physics, medical technology, medical leadership, and administration operate the facility, which is equipped with a latest-generation Varian TrueBeam linear accelerator supporting IMRT, RapidArc, and electron irradiation techniques, plus a planning CT scanner with optional PET imaging capability.

The business model is referral-driven and operates entirely within the Swiss mandatory health insurance system (KVG/BLG), with revenue generated through professional services billing. Patients access the facility via physician referrals (GPs, oncologists, specialists) using HIN-secured email channels, and the institute participates in tumor boards with BSS and KSO hospitals. Treatment planning is performed by Inselspital university specialist teams, with complex cases—including orthovoltage, contact, brachytherapy, stereotactic radiotherapy, and clinical trial access—referred to Inselspital Bern. IMRT for prostate cancer is delivered in close collaboration with Inselspital.

The company holds ISO 9001:2015 certification since 2017, audited by ClarCert GmbH (a DAkkS-accredited body), with recertification confirmed in 2022. Services are explicitly restricted to Switzerland and Swiss residents. A 2022 patient survey achieved a 78% response rate (49 of 63 patients) with high satisfaction across all treatment areas. The institute is governed by a board of directors chaired by Dr. rer. pol. Stephan Hill, with Roger Maier chairing the executive management, Dr. med. Patrick Wolfensberger serving as Medical Director, and Dr. Reto Küng heading medical physics.

Name

Radio-Oncology Solothurn AG

Legal name

Radio-Onkologie Solothurn AG

Website

https://radioonkologie-solothurn.ch

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

Radio-Onkologie Solothurn AG is a Swiss radiation oncology joint venture operating a single Varian TrueBeam facility in Solothurn, delivering university-level external beam radiotherapy to cancer patients in the Canton of Solothurn region via physician referrals.

Ownership category

akta.pro rank

Product category

Radiation Oncology Services

NAICS

Outpatient Care Centers (6214), Diagnostic Imaging Centers (621512)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industries

Radiation Oncology (HLAKAFAC), Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH), Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)

Keywords

• Radiation oncology services
• External beam radiotherapy
• Cancer treatment services
• Radiotherapy treatment planning
• Radiation therapy center

Headquarters

HQ city

Little Switzerland

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. Radiation Oncology Treatment Services: Healthcare provider delivering radiation therapy services to cancer patients. Revenue generated through Swiss health insurance system (KVG/BLG) - treatments are covered by mandatory health insurance and supplementary insurance. Services include planning CT, radiation therapy sessions, and follow-up consultations.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Radio-Onkologie Solothurn AG operates a radiation oncology institute providing external beam radiotherapy to cancer patients. Treatment is delivered via a latest-generation Varian TrueBeam linear accelerator, supported by planning CT imaging and university-level treatment planning performed at Inselspital Bern. Services cover IMRT, RapidArc, electron irradiation, simultaneous radio-chemotherapy, palliative metastasis therapy, and treatment of benign lesions, with daily sessions Monday through Friday at the Bürgerspital Solothurn location.

Product overview

Radio-Oncology Solothurn AG operates a radiation oncology institute offering comprehensive radiotherapy services. The core offering centers on the Varian TrueBeam linear accelerator for external beam radiotherapy, supplemented by planning CT imaging and specialized treatment planning performed in collaboration with Inselspital Bern. The facility provides multiple treatment techniques including IMRT, RapidArc, and electron irradiation for various cancer types. Treatment planning is outsourced to the university team at Inselspital Bern, where medical physicists calculate optimal radiation plans. Services are delivered through a structured patient pathway including initial consultation, planning CT, treatment planning, and ongoing treatment sessions with side effect monitoring.

Differentiator

Problem solved

Functional benefit

Products and services

• External Beam Radiation Therapy (Perkutane Strahlentherapie)

Quantifiable outcome

• 78% survey response rate (49 of 63 patients) with high satisfaction scores across all treatment areas

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Solothurner Spitäler AGcoreStrategic or Co-development Partner · 25 November 2011Parent company and co-founder of the joint venture. Operates the Bürgerspital Solothurn where the facility is located. Provides infrastructure, administrative support, and patient referral network. Radio-Onkologie Solothurn AG is an enterprise of Solothurner Spitäler AG.
• Inselspital / Universitätsspital BerncoreStrategic or Co-development Partner · 25 November 2011University hospital partner providing university-level expertise. Treatment planning is performed by university tumor-specific specialist teams. Complex cases are referred to Inselspital for orthovoltage, contact, brachytherapy, stereotactic radiotherapy, and clinical trials. IMRT for prostate cancer delivered in close collaboration with Inselspital.

Scale indicators2 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Centre hospitalier universitaire vaudois (CHUV): Major Swiss university hospital with a full radiation oncology service including advanced techniques and clinical research. Comparable as a publicly governed, French-speaking Swiss academic radiation oncology provider with similar JV/partnership structures.
• Universitätsspital Zürich (USZ): University hospital with a comprehensive radiation oncology department offering advanced techniques, clinical trials, and complex case management. Comparable as a Swiss tertiary radiation oncology provider operating at university level with a much broader footprint.
• Hirslanden Klinik: Switzerland's largest private hospital group, operating multiple radiation oncology sites across the country. Comparable as a multi-site Swiss radiotherapy provider, though predominantly private-pay rather than statutory insurance driven.

Direct peers

• Inselspital / Universitätsspital Bern: University hospital partner and co-owner of Radio-Onkologie Solothurn AG. Operates a full radiation oncology department including brachytherapy, stereotactic, and clinical trials. Direct peer in radiation oncology service delivery, with the closest overlap on patient pathways and clinical expertise.
• Kantonsspital St. Gallen (KSSG): Large regional Swiss hospital with a radiation oncology institute serving Eastern Switzerland. Comparable as a regional, non-university hospital operating a modern linac-based radiotherapy service with similar referral-based GTM.
• Universitätsspital Basel (USB): University hospital in Northwestern Switzerland with a full radiation oncology service. Comparable as a Swiss academic radiotherapy provider and a potential referral counterparty for cases that exceed Radio-Onkologie Solothurn's scope.
• Kantonsspital Luzern (LUKS): Central Swiss cantonal hospital with a radiation oncology center serving a similar regional catchment to Solothurn. Comparable as a regional cantonal hospital offering linear accelerator-based radiotherapy with physician referral intake.

Regional players

• Kantonsspital Baden (KSB): Regional cantonal hospital in Aargau with a radiation oncology service. Comparable as a regional Swiss hospital offering linear accelerator radiotherapy to a defined catchment, with similar referral-driven patient acquisition.
• MedAustron: Austrian center for ion beam therapy offering advanced radiotherapy. Comparable as a specialized radiation therapy center in the DACH region, though focused on particle therapy rather than conventional linac treatment.

Emerging players

• Paul Scherrer Institut (PSI): Swiss research institute operating the country's only proton and carbon-ion therapy center. Comparable as a Swiss radiation therapy provider, but focused on particle therapy for complex cases rather than conventional linac-based radiotherapy.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles24 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Radio-Oncology Solothurn AG